{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:09:51Z","timestamp":1697432991682},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ymgme.2010.09.006","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T09:49:37Z","timestamp":1285667377000},"page":"82-90","source":"Crossref","is-referenced-by-count":5,"title":["Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families"],"prefix":"10.1016","volume":"102","author":[{"given":"Maria","family":"Hietala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Henningson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"T\u00f6rngren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Jernstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.09.006_bb0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/md.0b013e3181946a2c","article-title":"Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism","volume":"88","author":"Karrer-Voegeli","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beem.2006.03.007","article-title":"Diagnosis of hyperandrogenism: biochemical criteria","volume":"20","author":"Stanczyk","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fertnstert.2007.05.057","article-title":"Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?","volume":"90","author":"Schover","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/er.2003-0016","article-title":"Testosterone effects on the breast: implications for testosterone therapy for women","volume":"25","author":"Somboonporn","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone","volume":"24","author":"Labrie","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ijc.20403","article-title":"Endogenous sex hormones and subsequent breast cancer in premenopausal women","volume":"112","author":"Micheli","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","article-title":"Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"97","author":"Kaaks","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0040","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"Key","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0045","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jnci\/djh336","article-title":"Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women","volume":"96","author":"Missmer","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0050","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/oxfordjournals.aje.a009059","article-title":"Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women","volume":"145","author":"Zeleniuch-Jacquotte","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr2413","article-title":"Androgens and the breast","volume":"11","author":"Dimitrakakis","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1018730519839","article-title":"Role of the androgen receptor in human breast cancer","volume":"3","author":"Birrell","year":"1998","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0065","first-page":"1067","article-title":"Joint effect of insulin-like growth factors and sex steroids on breast cancer risk","volume":"12","author":"Yu","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0070","unstructured":"The National Board of Health And Welfare, Cancer Incidence In Sweden 2008, Stockholm, Sweden, 2009."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-004-2172-4","article-title":"The \u201cportrait\u201d of hereditary breast cancer","volume":"89","author":"Lacroix","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1582-4934.2005.tb00350.x","article-title":"Understanding breast cancer risk\u2014where do we stand in 2005?","volume":"9","author":"Dumitrescu","year":"2005","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0095","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1073\/pnas.190353897","article-title":"Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells","volume":"97","author":"Yeh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0100","first-page":"127","article-title":"Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case\u2013control study of young women","volume":"12","author":"Suter","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0105","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.86.6.2562","article-title":"Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women","volume":"86","author":"Westberg","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0110","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2002-021791","article-title":"Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism","volume":"88","author":"Ibanez","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jsgi.2004.11.003","article-title":"Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women","volume":"12","author":"Brum","year":"2005","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/humrep\/del318","article-title":"Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women","volume":"22","author":"Hietala","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0125","first-page":"5869","article-title":"Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population","volume":"61","author":"Giguere","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0130","first-page":"848","volume":"12","author":"Liede","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0135","first-page":"1045","article-title":"The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study","volume":"62","author":"Haiman","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0140","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1086\/302366","article-title":"Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat","volume":"64","author":"Rebbeck","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00008469-199708000-00004","article-title":"Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19\u201325 years who were first and\/or second degree relatives to breast cancer patients","volume":"6","author":"Jernstr\u00f6m","year":"1997","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0150","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0155","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/sj.bjc.6602389","article-title":"Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families","volume":"92","author":"Jernstr\u00f6m","year":"2005","journal-title":"Br J. Cancer"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0160","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0165","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/bcr1602","article-title":"A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)","volume":"8","author":"Cox","year":"2006","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0170","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1158\/0008-5472.CAN-06-3024","article-title":"Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development","volume":"66","author":"Lindstr\u00f6m","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwh046","article-title":"Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review","volume":"159","author":"Modugno","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0180","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.80.4.1169","article-title":"Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study","volume":"80","author":"Carr","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1677\/joe.0.1620137","article-title":"Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men","volume":"162","author":"Krithivas","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/eje.0.1490469","article-title":"Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes","volume":"149","author":"Ntais","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2010.09.006_bb0195","series-title":"Hormonal Contraception and Post-menopasual Hormonal Therapy","author":"World Health Organization International Agency on Cancer","year":"1999"},{"key":"10.1016\/j.ymgme.2010.09.006_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/08035320600618783","article-title":"Skewed X inactivation in healthy individuals and in different diseases","volume":"95","author":"Orstavik","year":"2006","journal-title":"Acta Paediatr. Suppl."},{"issue":"11","key":"10.1016\/j.ymgme.2010.09.006_bb0205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/jmg.2005.032433","article-title":"High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1\/BRCA2 breast cancer","volume":"42","author":"Kristiansen","year":"2005","journal-title":"J. Med. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T20:29:12Z","timestamp":1544214552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210003471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1096719210003471"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.09.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}